The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Cancer Research Heroes The Power of Patient Samples Research Project REVIVE Announcement, Press Release The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer Research Update A Collaborative Effort Aims to Change the Future of Patient Care With Cancer Immunotherapy Point of View An Immunologist Breaks Down COVID-19 Announcement A message from PICI: Thank you to those addressing this global pandemic Announcement 2019 Annual Report
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer
Research Update A Collaborative Effort Aims to Change the Future of Patient Care With Cancer Immunotherapy